Ultrasound in Diagnosis of Retroperitoneal Fibrosis (Ormond’s disease)
Abstract
Literature review focuses on the diagnosis of retroperitoneal fibrosis (Ormond’s disease) - a rare disease characterized by an overproduction of fibro-inflammatory tissue of the retroperitoneal space around the aorta, inferior vena cava, and iliac vessels. The pathological process often causes obstructive uropathy, which can be the reason of kidney failure. Two cases of retroperitoneal fibrosis ultrasound diagnosis are presented. The ultrasound allows estimating localization, length of the lesion, adjacent structures involvement, presence of hydronephrosis and performing imaging follow-up during therapy.
About the Authors
E. V. Polukhina
Postgraduate Institute for Public Health Workers
Russian Federation
Russian Federation
L. O. Glazun
Postgraduate Institute for Public Health Workers
Russian Federation
Russian Federation
References
1. Vaglio A., Salvarani C., Buzio C. Retroperitoneal fibrosis // Lancet. 2006. V. 367. No. 9506. P. 241-251.
2. Brandt A.S., Kamper L., Kukuk S. et al. Associated findings and complications of retroperitoneal fibrosis in 204 patients: results of a urological registry // J. Urol. 2011. V. 185. No. 2. P. 526-531.
3. Corradi D., Maestri R., Palmisano A. et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis // Kidney Int. 2007. V. 72. No. 6. P. 742-753.
4. Palmisano A., Vaglio A. Chronic periaortitis: a fibro-inflammatory disorder // Best Pract. Res. Clin. Rheumatol. 2009. V. 23. No. 3. P. 339-353.
5. Scheel P.J. Jr., Feeley N. Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation // Medicine (Baltimore). 2009. V. 88. No. 4. P. 202-207.
6. Urban M.L., Palmisano A., Nicastro M. et al. Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach // Rev. Med. Interne. 2015. V. 36. No. 1. P. 15-21.
7. Van Bommel E.F., Jansen I., Hendriksz T.R., Aarnoudse A.L. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicradiologic presentation // Medicine (Baltimore). 2009. V. 88. No. 4. P. 193-201.
8. Parums D.V. The spectrum of chronic periaor titis // Histopathology. 1990. V. 16. No. 5. P. 423-431.
9. Li K.P., Zhu J., Zhang J.L. et al. Idiopathic retroperitoneal fibrosis (RPF): clinical features of 61 cases and literature review // Clin. Rheumatol. 2011. V. 30. No. 5. P. 601-605.
10. Khosroshahi A., Carruthers M.N., Stone J.H. et al. Rethinking Ormond’s disease: “idiopathic” retroperitoneal fibrosis in the era of IgG4-related disease // Medicine (Baltimore). 2013. V. 92. No. 2. P. 82-91.
11. Cronin C.G., Lohan D.G., Blake M.A. et al. Retroperitoneal fibrosis: a review of clinical features and imaging findings // Am. J. Roentgenol. 2008. V. 191. No. 1. P. 423-431.
12. Kermani T.A., Crowson C.S., Achenbach S.J., Luthra H.S. Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes // Mayo Clin. Proc. 2011. V. 86. No. 4. P. 297-303.
13. Корниенко В.И., Аль-Шухри С.Х., Люблинская А.А. Ретроперитонеальный фиброз (болезнь Ормонда) // Нефрология. 2009. Т. 13. № 3. С. 159-162.
14. Magrey M.N., Husni M.E., Kushner I., Calabrese L.H. Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis? // Arthritis Rheum. 2009. V. 61. No. 5. P. 674-679.
15. Парамонова Т.И., Горностаева О.С., Вдовкин А.В. и др. Идиопатический ретророперитонеалный фироз (болезнь Ормонда) // Диагностическая и интер венционная радиология. 2012. Т. 6. № 4. С. 103-111.
16. Caiafa R.O., Vinuesa A.S., Izquierdo R.S. et al. Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up // Radiographics. 2013. V. 33. No. 2. P. 535-552.
17. Rosenkrantz A.B., Spieler B., Seuss C.R. et al. Utility of MRI features for differentiation of retroperitoneal fibrosis and lymphoma // Am. J. Roentgenol. 2012. V. 199. No. 1. P. 118-126.
18. Jansen I., Hendriksz T.R., Han S.H. et al. (18) F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis // Eur. J. Intern. Med. 2010. V. 21. No. 3. P. 216-221.
19. Bowie J.D., Bernstein J.R. Retroperitoneal fibrosis: ultrasound findings and case report // J. Clin. Ultrasound. 1976. V. 4. No. 6. P. 435-437.
20. Болоцков А.С., Ильясов Б.Б., Куземко В.П. Перспективы ультразвуковой диагностики ретроперитонеального фиброза (болезни Ормонда) // Эхография. 2002. № 1. С. 13-15.
21. Moussavian B., Horrow M.M. Retroperitoneal fibrosis // Ultrasound Q. 2009. V. 25. No. 2. P. 89-91.
22. Partovi S., Imfeld S., Aschwanden M. et al. The use of contrast-enhanced ultrasound (CEUS) in chronic periaortitis // Ultraschall Med. 2013. V. 1. P. 3-6.
23. Alberici F., Palmisano A., Urban M.L. et al. Methotrexate plus prednisone in patients with relapsing idiopathic retroperioneal fibrosis // Ann. Rheum. Dis. 2013. V. 72. No. 9. P. 1584-1586.
24. Mehta A., Blodgett T.M. Retroperitoneal fibrosis as a cause of positive FDG PET/CT // J. Radiol. Case Rep. 2011. V. 5. No. 7. P. 35-41.
Review
For citations:
Polukhina E.V., Glazun L.O. Ultrasound in Diagnosis of Retroperitoneal Fibrosis (Ormond’s disease). Ultrasound & Functional Diagnostics. 2016;(5):11-21. (In Russ.)
Views:
74
Email this article 